Association of diabetes and cancer mortality in American Indians: the Strong Heart Study.

MedStar author(s):
Citation: Cancer Causes & Control. 26(11):1551-60, 2015 Nov.PMID: 26250516Institution: MedStar Health Research InstituteForm of publication: Journal ArticleMedline article type(s): Journal Article | Research Support, N.I.H., ExtramuralSubject headings: *Diabetes Mellitus/ep [Epidemiology] | *Indians, North American/sn [Statistics & Numerical Data] | *Neoplasms/ep [Epidemiology] | *Obesity/ep [Epidemiology] | Aged | Body Mass Index | Cohort Studies | Diabetes Mellitus/mo [Mortality] | Female | Humans | Incidence | Insulin Resistance | Male | Middle Aged | Neoplasms/mo [Mortality] | Obesity/mo [Mortality] | Prevalence | Prospective Studies | Smoking/ep [Epidemiology]Year: 2015ISSN:
  • 0957-5243
Name of journal: Cancer causes & control : CCCAbstract: CONCLUSIONS: Diabetes mellitus, and/or insulin resistance among those without diabetes, is a risk factor for gastric, hepatocellular, and prostate cancer in these American Indian communities, although relatively small sample size suggests cautious interpretation. Additional research is needed to evaluate the role of diabetes and obesity on cancer incidence in American Indian communities as well as the importance of diabetes prevention and control in reducing the burden of cancer incidence and mortality in the study population.METHODS: Among a total cohort of 4,419 participants who were followed for up to 20 years, 430 cancer deaths were identified.PURPOSE: The metabolic abnormalities that accompany diabetes mellitus are associated with an increased risk of many cancers. These associations, however, have not been well studied in American Indian populations, which experience a high prevalence of diabetes. The Strong Heart Study is a population-based, prospective cohort study with extensive characterization of diabetes status.RESULTS: After adjusting for sex, age, education, smoking status, drinking status, and body mass index, participants with diabetes at baseline showed an increased risk of gastric (HR 4.09; 95% CI 1.42-11.79), hepatocellular (HR 2.94; 95% CI 1.17-7.40), and prostate cancer mortality (HR 3.10; 95% CI 1.22-7.94). Further adjustment for arsenic exposure showed a significantly increased risk of all-cause cancer mortality with diabetes (HR 1.27; 95% CI 1.03-1.58). Insulin resistance among participants without diabetes at baseline was associated with hepatocellular cancer mortality (HR 4.70; 95% CI 1.55-14.26).All authors: Best LG, Farley JH, Garcia-Esquinas E, Howard BV, Lee ET, Navas-Acien A, Rhoades DA, Rhoades ER, Umans JG, Welty TK, Yeh F, Yeh JL, Zhang YFiscal year: FY2016Digital Object Identifier: Date added to catalog: 2016-06-06
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 26250516 Available 26250516

CONCLUSIONS: Diabetes mellitus, and/or insulin resistance among those without diabetes, is a risk factor for gastric, hepatocellular, and prostate cancer in these American Indian communities, although relatively small sample size suggests cautious interpretation. Additional research is needed to evaluate the role of diabetes and obesity on cancer incidence in American Indian communities as well as the importance of diabetes prevention and control in reducing the burden of cancer incidence and mortality in the study population.

METHODS: Among a total cohort of 4,419 participants who were followed for up to 20 years, 430 cancer deaths were identified.

PURPOSE: The metabolic abnormalities that accompany diabetes mellitus are associated with an increased risk of many cancers. These associations, however, have not been well studied in American Indian populations, which experience a high prevalence of diabetes. The Strong Heart Study is a population-based, prospective cohort study with extensive characterization of diabetes status.

RESULTS: After adjusting for sex, age, education, smoking status, drinking status, and body mass index, participants with diabetes at baseline showed an increased risk of gastric (HR 4.09; 95% CI 1.42-11.79), hepatocellular (HR 2.94; 95% CI 1.17-7.40), and prostate cancer mortality (HR 3.10; 95% CI 1.22-7.94). Further adjustment for arsenic exposure showed a significantly increased risk of all-cause cancer mortality with diabetes (HR 1.27; 95% CI 1.03-1.58). Insulin resistance among participants without diabetes at baseline was associated with hepatocellular cancer mortality (HR 4.70; 95% CI 1.55-14.26).

English

Powered by Koha